Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The efficacy of subcutaneous recombinant human erythropoietin in the correction of phlebotomy-induced anemia in autologous blood donors.

Biesma DH, Kraaijenhagen RJ, Marx JJ, van de Wiel A.

Transfusion. 1993 Oct;33(10):825-9.

PMID:
8236423
2.

[Effect of recombinant human erythropoietin on autologous blood donation for heart surgery].

Szöcs M, Donauer E, Simon J, Gál G, Kovács G.

Orv Hetil. 1995 Aug 13;136(33):1777-81. Review. Hungarian.

PMID:
7651714
3.

[Autologous blood pre-donation and perioperative use of erythropoietin].

Michaeli B, Ravussin P, Chassot PG.

Rev Med Suisse. 2006 Nov 22;2(88):2662-4, 2666-7. Review. French.

PMID:
17265804
4.

Management of chemotherapy-induced anemia.

Eguchi K.

Curr Opin Oncol. 1995 Jul;7(4):316-9. Review.

PMID:
7578378
5.

Toward bloodless surgery: erythropoietin therapy in the surgical setting.

Goodnough LT.

Semin Oncol. 1992 Jun;19(3 Suppl 8):19-24. Review.

PMID:
1615335
6.

Clinical application of recombinant erythropoietin in the perioperative period.

Goodnough LT.

Hematol Oncol Clin North Am. 1994 Oct;8(5):1011-20. Review.

PMID:
7852209
7.

The use of erythropoietin in the treatment of post-bone marrow transplantation anemia.

Vannucchi AM, Bosi A, Grossi A, Guidi S, Saccardi R, Bacci P, Lombardini L, Rossi-Ferrini P.

Int J Artif Organs. 1993 Dec;16 Suppl 5:8-12. Review.

PMID:
8014003
8.

Increasing autologous blood donation with recombinant human erythropoietin.

Levine EA.

Contrib Nephrol. 1991;88:327-33. Review. No abstract available.

PMID:
2040195
9.

Adverse events of erythropoietin in long-term and in acute/short-term treatment.

Singbartl G.

Clin Investig. 1994;72(6 Suppl):S36-43. Review.

PMID:
7950171
10.

Recombinant human erythropoietin enhances blood donation for autologous use and reduces exposure to homologous blood during elective surgery.

Mercuriali F, Adamson JW.

Semin Hematol. 1993 Oct;30(4 Suppl 6):17-21. Review. No abstract available.

PMID:
8153672
11.

Erythropoietin--does it increase the efficiency of autologous blood donation?

Goodnough LT.

Beitr Infusionsther. 1993;29:240-50. Review. No abstract available.

PMID:
7690657
12.

The role of recombinant human erythropoietin in homologous transfusion avoidance.

Sobota JT.

Contrib Nephrol. 1991;88:334-48; discussion 349-50. Review. No abstract available.

PMID:
2040196
13.

Implementation of a predonation system.

Cable RG.

Int Anesthesiol Clin. 1982 Winter;20(4):59-76. Review. No abstract available.

PMID:
6757145
14.

[Eprex and daily autologous transfusion].

Chassaigne M, Desbois I, Decilap C.

Nouv Rev Fr Hematol. 1995;37 Suppl 1:S37-40. Review. French. No abstract available.

PMID:
7478983
15.

Autologous transfusion--too far, too soon?

Gillon J, Bell K, Prescott RJ.

Vox Sang. 1991;61(2):81-3. Review. No abstract available.

PMID:
1763502
16.

Preoperative autologous donation: what was the impact of the 1995 consensus statement?

Thomas MJ, Desmond M, Gillon J.

Transfus Med. 1999 Sep;9(3):241-57. Review. No abstract available.

PMID:
10555818
17.

Recombinant human erythropoietin patient dosing algorithm.

Muirhead N.

Semin Nephrol. 1990 Mar;10(2 Suppl 1):59-65. Review. No abstract available.

PMID:
2192418
18.

Fainting: a review of its mechanisms and a study in blood donors.

Ruetz PP, Johnson SA, Callahan R, Meade RC, Smith JJ.

Medicine (Baltimore). 1967 Sep;46(5):363-84. Review. No abstract available.

PMID:
4864338

Supplemental Content

Support Center